- Home
- TTWO vs ILMN Comparison
TTWO vs ILMN Comparison
Compare TTWO & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTWO
- ILMN
- Stock Information
- Founded
- TTWO 1993
- ILMN 1998
- Country
- TTWO United States
- ILMN United States
- Employees
- TTWO N/A
- ILMN N/A
- Industry
- TTWO Computer Software: Prepackaged Software
- ILMN Medical Specialities
- Sector
- TTWO Technology
- ILMN Health Care
- Exchange
- TTWO Nasdaq
- ILMN Nasdaq
- Market Cap
- TTWO 40.2B
- ILMN 13.1B
- IPO Year
- TTWO 1997
- ILMN 2000
- Fundamental
- Price
- TTWO $241.72
- ILMN $100.63
- Analyst Decision
- TTWO Strong Buy
- ILMN Buy
- Analyst Count
- TTWO 23
- ILMN 16
- Target Price
- TTWO $225.00
- ILMN $126.88
- AVG Volume (30 Days)
- TTWO 2.0M
- ILMN 2.3M
- Earning Date
- TTWO 08-07-2025
- ILMN 08-05-2025
- Dividend Yield
- TTWO N/A
- ILMN N/A
- EPS Growth
- TTWO N/A
- ILMN N/A
- EPS
- TTWO N/A
- ILMN N/A
- Revenue
- TTWO $5,633,600,000.00
- ILMN $4,337,000,000.00
- Revenue This Year
- TTWO $8.35
- ILMN N/A
- Revenue Next Year
- TTWO $53.69
- ILMN $3.11
- P/E Ratio
- TTWO N/A
- ILMN N/A
- Revenue Growth
- TTWO 5.31
- ILMN N/A
- 52 Week Low
- TTWO $135.24
- ILMN $68.70
- 52 Week High
- TTWO $245.08
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- TTWO 57.45
- ILMN 81.33
- Support Level
- TTWO $237.31
- ILMN $88.68
- Resistance Level
- TTWO $244.50
- ILMN $95.99
- Average True Range (ATR)
- TTWO 5.21
- ILMN 2.91
- MACD
- TTWO -0.30
- ILMN 0.93
- Stochastic Oscillator
- TTWO 66.17
- ILMN 97.37
About TTWO Take-Two Interactive Software Inc.
Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.